Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2026.1739810 Correction Correction: The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome WangQiuyi 1 2 Methodology Formal analysis Investigation Writing – original draft LiangJiagui 1 2 Data curation Investigation Resources Writing – original draft LiuQingqing 2 Project administration Validation Writing – original draft LiuHongwei 1 2 Data curation Resources Supervision Writing – review & editing BaiHuai 2 Supervision Writing – review & editing HuangWei 1 3 * Conceptualization Resources Supervision Writing – review & editing FanPing 2 * Conceptualization Formal analysis Funding acquisition Methodology Writing – review & editing Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Department of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Correspondence: Wei Huang, weihuang64@163.com; Ping Fan , fanping15@scu.edu.cn 20 01 2026 2026 17 1739810 05 11 2025 09 01 2026 08 01 2026 Copyright © 2026 Wang, Liang, Liu, Liu, Bai, Huang and Fan. 2026 Wang, Liang, Liu, Liu, Bai, Huang and Fan https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on: The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome By Wang Q, Liang J, Liu Q, Liu H, Bai H, Huang W and Fan P (2025) Front. Endocrinol. 16:1644373. doi: 10.3389/fendo.2025.1644373 heme oxygenase-1 genetic polymorphism polycystic ovarian syndrome oxidative stress metabolism National Natural Science Foundation of China 10.13039/501100001809 section-at-acceptance Reproduction

There were mistakes in Table 2 as published:

In the unadjusted OR (95% CI) column, the word ‘Referent’ missed in lines 3 and 18.

Revision of data in the OR value in line 9 from 1.257 to 1.275 and the 95% CI value in last line from (0.950-0.239) to (0.950–1.229).

Revision of data in the OR (95% CI) column, some hyphens from “-” to “–”].

The corrected Table 2 appears below (The red font represents the modified contents).

Association of HMOX1 T-413A (rs2071746) and (GT)n repeat polymorphisms with the risk of PCOS using different genetic models.

Variants Controls (n = 805) PCOS (n = 1092) Unadjusted Adjusted
OR (95% CI) P OR (95% CI) P
T-413A (rs2071746)
Genotype
AA 173 (21.5%) 193 (17.7%) Referent
AT 426 (52.9%) 556 (50.9%) 1.170 (0.919–1.489) 0.201 1.140 (0.872–1.493) 0.342
TT 206 (25.6%) 343 (31.4%) 1.493 (1.141–1.952) 0.003 1.395 (1.033–1.883) 0.030
PHWE 0.233 0.456
Recessive
TT + AT 632 (78.5%) 899 (82.3%)
AA 173 (21.5%) 193 (17.7%) 1.275 (1.014–1.603) 0.037 1.212 (0.936–1.570) 0.144
Dominant
TT 206 (25.6%) 343 (31.4%)
AA + AT 599 (74.4%) 749 (68.6%) 1.332 (1.086–1.632) 0.006 1.272 (1.013–1.597) 0.039
Allele
A 772 (48.0%) 942 (43.1%)
T 838 (52.0%) 1242 (56.9%) 1.215 (1.067–1.382) 0.003 / /
(GT)n repeat
Genotype
LL 224 (27.8%) 298 (27.3%) Referent
SL 422 (52.4%) 542 (49.6%) 0.965 (0.779–1.197) 0.748 0.935 (0.736–1.189) 0.584
SS 159 (19.8%) 252 (23.1%) 1.191 (0.915–1.551) 0.193 1.134 (0.844–1.522) 0.404
PHWE 0.292 0.983
Recessive
LL + SL 646 (80.2%) 840 (76.9%)
SS 159 (19.8%) 252 (23.1%) 1.219 (0.975–1.524) 0.082 0.842 (0.655–1.081) 0.178
Dominant
LL 224 (27.8%) 298 (27.3%)
SS + SL 581 (72.2%) 794 (72.7%) 0.973 (0.794–1.193) 0.796 1.041 (0.827–1.309) 0.733
Allele
L 870 (54.0%) 1138 (52.1%)
S 740 (46.0%) 1046 (47.9%) 1.081 (0.950–1.229) 0.239 / /

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Edited and reviewed by: Edgar Ricardo Vázquez-Martínez, National Autonomous University of Mexico, Mexico